A nonsynonymous mutation in plcg2 reduces the risk of alzheimer’s disease, dementia with lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

HIGHLIGHTS

• who: Sven J. van der Lee from the (UNIVERSITY) have published the article: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity, in the Journal: (JOURNAL)
• what: The authors used maternal and paternal history of Alzheimer's/dementia as proxy for dementia and the reported age of the parents (at completing the survey or death) as proxy phenotype for longevity . In this analysis, the authors compared 35,256 UK Biobank participants who had a mother who reached at least . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.